Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Apr 28, 2017 | $113B |
| FY2018, ended Apr 27, 2018 | $110B |
| FY2019, ended Apr 26, 2019 | $117B |
| FY2020, ended Apr 24, 2020 | $133B |
| FY2021, ended Apr 30, 2021 | $176B |
| FY2022, ended Apr 29, 2022 | $139B |
| FY2023, ended Apr 28, 2023 | $121B |
| FY2024, ended Apr 26, 2024 | $102B |
| FY2025, ended Apr 25, 2025 | $108B |
| FY2026, ended Apr 24, 2026 | $107B |
| Trailing 12 months to Jul 31, 2026 (through Q1 FY2027) | $109B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Apr 28, 2017 | $29.7B |
| FY2018, ended Apr 27, 2018 | $30.0B |
| FY2019, ended Apr 26, 2019 | $30.6B |
| FY2020, ended Apr 24, 2020 | $28.9B |
| FY2021, ended Apr 30, 2021 | $30.1B |
| FY2022, ended Apr 29, 2022 | $31.7B |
| FY2023, ended Apr 28, 2023 | $31.2B |
| FY2024, ended Apr 26, 2024 | $32.4B |
| FY2025, ended Apr 25, 2025 | $33.5B |
| FY2026, ended Apr 24, 2026 | $36.4B |
| Trailing 12 months to Jul 31, 2026 (through Q1 FY2027) | $37.5B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Apr 28, 2017 | $4.03B | $5.63B |
| FY2018, ended Apr 27, 2018 | $3.10B | $3.62B |
| FY2019, ended Apr 26, 2019 | $4.63B | $5.87B |
| FY2020, ended Apr 24, 2020 | $4.79B | $6.02B |
| FY2021, ended Apr 30, 2021 | $3.61B | $4.88B |
| FY2022, ended Apr 29, 2022 | $5.04B | $5.98B |
| FY2023, ended Apr 28, 2023 | $3.76B | $4.58B |
| FY2024, ended Apr 26, 2024 | $3.68B | $5.20B |
| FY2025, ended Apr 25, 2025 | $4.66B | $5.18B |
| FY2026, ended Apr 24, 2026 | $4.80B | $5.43B |
| Trailing 12 months to Jul 31, 2026 (through Q1 FY2027) | $5.23B | $6.13B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Apr 28, 2017 | $4.97B |
| FY2018, ended Apr 27, 2018 | $3.67B |
| FY2019, ended Apr 26, 2019 | $4.39B |
| FY2020, ended Apr 24, 2020 | $4.14B |
| FY2021, ended Apr 30, 2021 | $3.59B |
| FY2022, ended Apr 29, 2022 | $3.71B |
| FY2023, ended Apr 28, 2023 | $1.54B |
| FY2024, ended Apr 26, 2024 | $1.28B |
| FY2025, ended Apr 25, 2025 | $2.22B |
| FY2026, ended Apr 24, 2026 | $1.95B |
| Trailing 12 months to Jul 31, 2026 (through Q1 FY2027) | $1.69B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Apr 28, 2017 | $33.4B |
| FY2018, ended Apr 27, 2018 | $25.8B |
| FY2019, ended Apr 26, 2019 | $25.4B |
| FY2020, ended Apr 24, 2020 | $24.9B |
| FY2021, ended Apr 30, 2021 | $26.4B |
| FY2022, ended Apr 29, 2022 | $24.1B |
| FY2023, ended Apr 28, 2023 | $24.4B |
| FY2024, ended Apr 26, 2024 | $25.0B |
| FY2025, ended Apr 25, 2025 | $28.5B |
| FY2026, ended Apr 24, 2026 | $28.0B |
| Trailing 12 months to Jul 31, 2026 (through Q1 FY2027) | $28.2B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 5.9% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Apr 28, 2017 | 1.36B |
| FY2018, ended Apr 27, 2018 | 1.35B |
| FY2019, ended Apr 26, 2019 | 1.34B |
| FY2020, ended Apr 24, 2020 | 1.34B |
| FY2021, ended Apr 30, 2021 | 1.34B |
| FY2022, ended Apr 29, 2022 | 1.33B |
| FY2023, ended Apr 28, 2023 | 1.33B |
| FY2024, ended Apr 26, 2024 | 1.28B |
| FY2025, ended Apr 25, 2025 | 1.28B |
| FY2026, ended Apr 24, 2026 | 1.28B |
| Trailing 12 months to Jul 31, 2026 (through Q1 FY2027) | 1.28B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2017, ended Apr 28, 2017 | $3.54B | $348M | — |
| FY2018, ended Apr 27, 2018 | $2.17B | $344M | — |
| FY2019, ended Apr 26, 2019 | $2.88B | $290M | — |
| FY2020, ended Apr 24, 2020 | $1.33B | $297M | — |
| FY2021, ended Apr 30, 2021 | $652M | $344M | — |
| FY2022, ended Apr 29, 2022 | $2.54B | $359M | — |
| FY2023, ended Apr 28, 2023 | $645M | $355M | — |
| FY2024, ended Apr 26, 2024 | $2.14B | $393M | $284M |
| FY2025, ended Apr 25, 2025 | $3.23B | $429M | $508M |
| FY2026, ended Apr 24, 2026 | $1.03B | $457M | $516M |
| Trailing 12 months to Jul 31, 2026 (through Q1 FY2027) | $1.18B | $496M | $441M |
Valuation
At current price- Market Cap
- $120B
- P/E
- 23.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.2×
- Price / Book
- 2.4×
- EV / EBITDA
- 15.1×
Growth
Trailing 12 months- Revenue (TTM)
- $37.5B
- Revenue Growth YoY
- 9.8%
- Revenue CAGR 3Y
- 5.2%
- Revenue CAGR 5Y
- 3.8%
- EPS Growth YoY
- 12.2%
- Net Income Growth YoY
- 12.3%
Profitability
Trailing 12 months- Gross Margin
- 65.0%
- Operating Margin
- 18.1%
- Net Margin
- 13.9%
- FCF Margin
- 16.3%
- Return on Equity
- 10.7%
Earnings
Trailing 12 months- Net Income
- $5.23B
- EPS (diluted)
- $4.06
- EBITDA
- $9.72B
- Operating Income
- $6.79B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $1.69B
- Total Debt
- $28.2B
- Net Debt
- $26.5B
- Total Assets
- $93.3B
- Total Liabilities
- $42.5B
- Shareholders' Equity
- $50.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $8.04B
- Capital Expenditure
- $1.90B
- Free Cash Flow
- $6.13B
Dividends and risk
Last 12 months- Dividend Yield
- 3.0%
- Dividend / Share
- $2.86
- Beta (5Y)
- 0.55
Every ratio is calculated from the company’s reported figures.